Cervical cancer rates and deaths are increasing around the world, with the highest rates in sub-Saharan Africa.

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy cells.

New research identifies molecular signatures in SCLC that could improve immunotherapy outcome prediction beyond conventional staging.

A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.

The study followed 4,190 adults with stage 2 hypertension in Pakistan for 12 months, who had their blood pressure continuously monitored using a wrist-worn fitness tracker.

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Two major studies have identified the most accurate non-invasive tests for diagnosing and assessing the severity of metabolic dysfunction-associated steatotic liver disease (MASLD), potentially ...

For decades, researchers have relied on gene expression to help decipher how genetic variation contributes to disease. However, what if significant genetic effects take place before changes in gene ...

Switching briefly to a low-fat diet at the onset of an inflammatory disease such as psoriasis could have major repercussions on its trajectory in both the short and long term, preclinical research ...

A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.